Keynote: Keith Yamamoto, Ph.D., President of AAAS and Special Advisor to the Chancellor for Science Policy and Strategy, University of California, San Francisco
The AI in Cancer Research and Clinical Care: Turning Promise into Reality Symposium, jointly sponsored by Frederick National Laboratory for Cancer Research and Hood College is coming up on September 20-22, 2022. This event will feature thought leaders discussing the state-of-the-art for several cancer research areas and clinical applications. This includes:
- Issues and challenges in greater utilization of AI such as reproducibility, portability, auditability, standards, regulatory compliance, etc.
- The ways in which AI and computation are used in cancer research and clinical applications, such as imaging, genomics, analytics, molecular modeling, complex systems modeling, accelerated drug discovery, predictive radiation oncology, and pathology.
For more information, visit the event website at https://www.hood.edu/discover/frederick-maryland/partnerships/ai-cancer-research-and-clinical-care-turning-promise-reality.